No information is available on the use of carmustine during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, especially alkylating agents such as carmustine.[1] The manufacturer recommends that breastfeeding be discontinued during carmustine therapy and for 1 month after the last dose.
关于卡莫司汀在母乳喂养期间的使用尚无可用信息。大多数资料认为，在母亲接受抗肿瘤药物治疗期间，尤其是使用卡莫司汀等烷化剂时，母乳喂养是禁忌的。[1]制造商建议在卡莫司汀治疗期间及最后一剂后1个月内停止母乳喂养。
